References
- Human cancer markers, S. Sell, B Wahren. Human Press Inc., Clifton, NJ 1982
- Tumor marker antigens, J. Holmgren. Studentlitteratur, Lund 1985
- Gold P., Freedman S. O. DEmonstration of tumor specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J. Exp. Med. 1965; 121: 439
- Benchimol S., Fuks A., Jothy S., Beachemin M., Shirota K., Stanners C. P. Carcinoembryonic antigen, a human tumor marker, functions as an intracellular adhesion molecule. CeU 1989; 57: 327
- Rieger Å., Wahren B. CEA levels in recurrence and metastases; the importance in detecting secondary disease. Scand. J. Gastroent. 1975; 10: 869
- Holyoke E. D., Evans J. T., Mittelman A. Carcinoembryonic antigen as a tumor marker. Biochemical markers for cancer, T. M. Chu. Marcel Dekker Inc., NY 1982; 61
- Wahren B., Harmenberg U., Edsmyr F., Jakobsson P., Ingimarsson S. Possible tumor markers in patients with oesophagus cancer. Scand. J. Gastroenterol. 1979; 14: 361
- Lo Gerfo P., Herter FP. Carcinoembryonic antigen and prognosis in patients with colon cancer. Ann. Surg. 1975; 181: 81
- Robinson W. Hepatitis B virus. Virology, B. N. Fields. Raven Press, NY 1985; 1384
- Sell S. Cancer markers of the 1990s. Clin. Lab. Med. 1990; 10: 1
- Koprowski H., Steplewski Z., Mitchell K., Herlyn M., Herlyn D., Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somat. Cell Genet. 1979; 5: 957
- Harmenberg U., Wahren B., Wiechel K.-L. Tumor markers carbohydrate antigens CA 19–9 and CA-50 and caicinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract. Cancer Res. 1988; 48: 1985
- Lindho IML., Holmgren J., Svennerholm L., Fredman L., Nilsson O., Persson B., Myrvold H., Lagergå RDT. Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. Int. Arch. Allergy Appl. Immunol. 1983; 71: 178
- Verrill H., Goldberg M., Rosenbaum R., Abbott R., Simunovic L., Steplewski Z., Koprowski H. Clinical trail of Wistar institute 17–1A monoclonal antibody in patients with advanced gastrointestinal adenocarcinoma: A preliminary report. Hybridoma 1986; 5: S175
- Frödin J.-E., Harmenberg U., Biberfeld P., Christensson B., Lefvert A.-K., Rieger A., Shetye J., Wahren B., Mellstedt H. Clinical effects of monoclonal antibodies (MAb 17–1 A) in patients with metastatic colorectal carcinomas. Hybridoma 1988; 7: 309
- Fishman W. H. Perspectives on alkaline phosphatase isoenzymes. Am. J. Med. 1974; 56: 617
- Seargent L. E., Stinson R. A. Evidence that three structural genes code for human alkaline phosphatases. Nature 1979; 281: 152
- Koshida K., Wahren B. Placental-like alkaline phosphatase in seminoma. UroL Res. 1990; 18: 87
- Harmenberg U., Koha M., Makiya Koshida R. K., Brismar B., Stigbrand T., Wahren B. Identification and characterization of alkaline phosphatase isoenzymes in human colorectal adenocarcinomas. Tumor Biol. 1991, in press
- Wahren B., Hammerström S., Harmenberg U., von Krusenstierna S., Larsson S.-A., Lundell G., Rudén U., Schnell P.-O. Polyclonal and monoclonal anti- CEA antibodies in immunolocalization of colorectal cancer. Tumor Biol. 1986; 7: 361
- Jeppson A., Wahrén B., Millá N, Stigbrand T. Localization of human tumor xenografts by 125I-laed monoclonal and polyclonal antibodies to placental alkaline phosphatase. Human alkaline phosphatases, T. Stigbrand, W. Fishman. Alan R. Liss Inc., NY 1984; 257
- Harmenberg U. Tumor markers of adenocarcinomas in colon and pancreas. Thesis, Karolinska Institute, Stockholm 1991